mdm2 mRNA Level is a Prognostic Factor in Soft Tissue Sarcoma

Molecular Medicine

Volumn 6, Issue 1, 2000, Pages 50-59

  Taubert, Helge ^a   Koehler, Thomas ^b   Meye, Axel ^a   Bartel, Frank ^a   Lautenschläger, Christiane ^a   Borchert, Silke ^b   Bache, Matthias ^a   Schmidt, Hannelore ^a   Würl, Peter ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Gene Therapeutic Approaches; Integrated Separation Systems; Mdm2 mRNA Expression; MDM2 Protein; Soft Tissue Sarcomas (STS)

Indexed keywords

MDM2 PROTEIN, HUMAN; MESSENGER RNA; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53; RNA;

ARTICLE; BIOSYNTHESIS; CANCER STAGING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MORTALITY; MULTIVARIATE ANALYSIS; MUTATION; NUCLEOTIDE SEQUENCE; PROGNOSIS; SARCOMA;

DNA MUTATIONAL ANALYSIS; HUMANS; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM STAGING; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RNA, MESSENGER; RNA, NEOPLASM; SARCOMA; TUMOR SUPPRESSOR PROTEIN P53;

MLCS; MLOWN;

EID: 0033655386     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03401934     Document Type: Article

References (63)

1. L.T. Cahilly-Snyder T. Yang-Feng U. Franke D.L. George Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line Somat. Cell Mol. Genet. 1987 13 235 244 10.1007/BF01535205 1:CAS:528:DyaL2sXkvFWisb0%3D 3474784
2. S.S. Fakharzadeh S.P. Trusko D.L. George Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line EMBO J. 1991 10 1565 1569 2026149 452821 1:CAS:528:DyaK38XnslGhug%3D%3D 10.1002/j.1460-2075.1991.tb07676.x
3. J.D. Oliner K.W. Kinzler P.S. Meltzer D.L. George B. Vogelstein Amplification of a gene encoding a p53-associated protein in human sarcomas Nature 1992 358 80 83 10.1038/358080a0 1:CAS:528:DyaK3sXisFagsbs%3D 1614537
4. M. Ladanyi C. Cha R. Lewis S.C. Jahnwar A.G. Huvos J.A. Healey mdm2 gene amplification in metastatic osteosarcoma Cancer Res. 1993 53 16 18 1:STN:280:DyaK3s7gsFCjtw%3D%3D 8416741
5. F.S. Leach T. Tokino P. Meltzer et al. p53 mutation and mdm2 amplification in human soft tissue sarcomas Cancer Res. 1993 53 2231 2234 1:STN:280:DyaK3s3ltFCnsQ%3D%3D 8387391
6. G. Reifenberger L. Liu K. Ichimura E.E. Schmidt V.P. Collins Amplification and overexpression of the mdm2 gene in a subset of human malignant gliomas without p53 mutations Cancer Res. 1993 53 2736 2739 1:CAS:528:DyaK3sXltlKmtLY%3D 8504413
7. C. Cordon-Cardo E. Latres M. Drobnjak et al. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas Cancer Res. 1994 54 794 799 1:CAS:528:DyaK2cXhs1Sgsb4%3D 8306343
8. M. Meddeb A. Valent G. Danglot et al. mdm2 amplification in a primary alveolar rhabdomyosarcoma displaying a t(2;13)(q35;q14) Cytogenet. Cell Genet. 1996 73 325 330 10.1159/000134368 1:CAS:528:DyaK28XlvVWhs7k%3D 8751388
9. J. Piette H. Neel V. Marechal mdm2: keeping p53 under control Oncogene 1997 15 1001 1010 10.1038/sj.onc.1201432 1:CAS:528:DyaK2sXmtVKisrw%3D 9285554
10. Y. Barak M. Oren Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest EMBO J. 1992 11 2115 2121 1600943 556678 1:CAS:528:DyaK38XkvVOnsbY%3D 10.1002/j.1460-2075.1992.tb05270.x
11. J. Momand G.P. Zambetti D. Olson D. George A.J. Levine The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Cell 1992 69 1237 1245 10.1016/0092-8674(92)90644-R 1:CAS:528:DyaK3sXit1Ogs7o%3D 1535557
12. Y. Barak T. Juven R. Haffner M. Oren mdm2 expression is induced by wild type p53 activity EMBO J. 1993 12 461 468 8440237 413229 1:CAS:528:DyaK3sXhtFyhsrk%3D 10.1002/j.1460-2075.1993.tb05678.x
13. C.A. Finlay The mdm2 oncogene can overcome wild type p53 suppression of transformed cell growth Mol. Cell Biol. 1993 13 301 306 10.1128/MCB.13.1.301 1:CAS:528:DyaK3sXpsFCqsg%3D%3D 8417333 358909
14. Y. Haupt Y. Barak M. Oren Cell type specific inhibition of p53-mediated apoptosis by mdm2 EMBO J. 1993 15 1596 1606 10.1002/j.1460-2075.1996.tb00504.x
15. P.H. Kussie S. Gorina V. Marechal et al. Structure of the mdm2 oncoproteine bound to the p53 tumor suppressor transactivation domain Science 1996 274 948 953 10.1126/science.274.5289.948 1:CAS:528:DyaK28XmslKnt7k%3D 8875929
16. Y. Haupt Y. Barak M. Oren Cell type-specific inhibition of p53-mediated apoptosis by mdm2 EMBO J. 1996 15 1596 1606 8612583 450069 1:CAS:528:DyaK28XisVOmtLc%3D 10.1002/j.1460-2075.1996.tb00504.x
17. Y. Haupt R. Maya A. Kazaz M. Oren mdm2 promotes the rapid degradation of p53 Nature 1997 387 296 299 10.1038/387296a0 1:CAS:528:DyaK2sXjtlSgtL8%3D 9153395
18. M.H.G. Kubbutat S.N. Jones K.H. Vousden Regulation of p53 stability by mdm2 Nature 1997 387 299 303 10.1038/387299a0 1:CAS:528:DyaK2sXjtlSgtLc%3D 9153396
19. R. Honda H. Tanaka H. Yasuda Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 FEBS Lett. 1997 420 25 27 10.1016/S0014-5793(97)01480-4 1:CAS:528:DyaK2sXotVyjtrg%3D 9450543
20. R. Honda H. Yasuda Association of p19ARF with mdm2 inhibits ubiquitin ligase activity of mdm2 for tumor suppressor p53 EMBO J. 1999 18 22 27 10.1093/emboj/18.1.22 1:CAS:528:DyaK1MXntVOguw%3D%3D 9878046 1171098
21. J.-K. Hsieh F.S.G. Chan D.J. O’Connor S. Mittnacht S. Zhong X. Lu Rb regulates the stability and the apoptotic function of p53 via mdm2 Mol. Cell 1999 3 181 193 10.1016/S1097-2765(00)80309-3 1:CAS:528:DyaK1MXhs12rsbo%3D 10078201
22. P. Leng D.R. Brown S. Deb S.P. Deb The human oncoprotein MDM2 binds to the human TATA-binding protein in vivo and in vitro Int. J. Oncol. 1995 6 251 259 21556531 1:CAS:528:DyaK2MXjsF2jsL0%3D
23. K. Martin D. Trouche C. Hagemeier T.S. Sorensen N.B. La Thangue T. Kouzarides Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein Nature 1995 375 691 694 10.1038/375691a0 1:CAS:528:DyaK2MXmsFKrt7g%3D 7791903
24. Z.X. Xiao J. Chen A.J. Levine et al. Interaction between the retinoblastoma protein and the oncoprotein mdm2 Nature 1995 375 694 698 10.1038/375694a0 1:CAS:528:DyaK2MXmsFKrt7k%3D 7791904
25. K. Lundgren R.M.D.O. Luna Y.B. McNeill et al. Targeted expression of mdm2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53 Genes Dev. 1997 11 714 725 10.1101/gad.11.6.714 1:CAS:528:DyaK2sXisVCrsbo%3D 9087426
26. P. Sun P. Dong K. Dai G.J. Hannon D. Beach p53-independent role of mdm2 in TGF-β resistance Science 1998 282 2270 2272 10.1126/science.282.5397.2270 1:CAS:528:DyaK1cXotFGjtrc%3D 9856953
27. D.R. Brown C.A. Thomas S.P. Deb The human oncoprotein mdm2 arrests the cell cycle: elimination of ist cell-cycle-inhibitory function induces tumorigenesis EMBO J 1999 9 2513 2525
28. D.A. Freedman L. Wu A.J. Levine Functions of the MDM2 oncoprotein Cell Mol. Life Sci. 1999 55 96 107 10.1007/s000180050273 1:CAS:528:DyaK1MXhtV2lsLY%3D 10065155
29. P. Würl A. Meye H. Schmidt et al. High prognostic significance of mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities Oncogene 1998 16 1183 1185 10.1038/sj.onc.1201646 9528860
30. C.E. Buesos-Ramos Y. Yang E. deLeon P. McDown S.A. Strass M. Albitar The human mdm2 oncogene is overexpressed in leukemias Blood 1993 82 2617 2623
31. Y. Barak E. Gottlieb T. Juven-Gershon M. Oren Regulation of mdm2 expression by p53: alternative promoters produce transcripts with nonidentical translation potential Genes Dev. 1994 8 1739 1749 10.1101/gad.8.15.1739 1:CAS:528:DyaK2cXlslajtLc%3D 7958853
32. T. Watanabe T. Hotta A. Ichikawa T. Kinoshita H. Nagai T. Uchida The mdm2 oncogene overexpression in chronic lymphocytic and low-grade lymphoma of B-cell origin Blood 1994 84 3158 3165 7949188 1:CAS:528:DyaK2MXhslOlur4%3D
33. J.E. Landers D.S. Haines J.F. Straus D.L. George Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells Oncogene 1994 9 2745 2750 1:CAS:528:DyaK2cXlslKgt7Y%3D 8058341
34. J.E. Landers S. Cassel D. George Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein Cancer Res. 1997 57 3562 3568 9270029 1:CAS:528:DyaK2sXls1Sgsrg%3D
35. R.E. Pollock A. Lang A.K. El-Naggar R. Radinsky M.C. Hung Enhanced mdm2 oncoprotein expression in soft tissue sarcoma: several possible mechanisms Sarcoma 1997 1 23 29 10.1080/13577149778443 1:STN:280:DC%2BD1czls1Gitw%3D%3D 18521197 2373579
36. D.C. Olson V. Marechal J. Momand J. Chen C. Romocki A.J. Levine Identification and characterisation of multiple mdm2 proteins and mdm2-p53 protein complexes Oncogene 1993 8 2353 2360 7689721 1:CAS:528:DyaK3sXms1Okt78%3D
37. J.M. Gudas H. Nguyen R.C. Klein D. Katayose P.M. Seth K.H. Cowan Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells Clin. Cancer Res. 1995 1 71 80 9815889 1:CAS:528:DyaK2MXlvVarsr0%3D
38. I. Sigalas A.H. Calvert J.J. Anderson D.E. Neal J. Lunec Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer Nature Med. 1996 2 912 917 10.1038/nm0896-912 1:CAS:528:DyaK28XkslGhs7w%3D 8705862
39. R. Matsumoto M. Tada M. Nozaki C.L. Zhang Y. Sawamura H. Abe Short alternative splice transcripts of the mdm2 oncogene correlate to malignancy in human astrocytic neoplasms Cancer Res. 1998 58 609 613 9485008 1:CAS:528:DyaK1cXht1antLs%3D
40. V.A. Florenes G.M. Maelandsmo A. Forus A. Andreassen O. Myklebost O. Fodstad mdm2 gene amplification and transcript levels in human sarcomas. Relationship to tp53 gene status J. Natl. Cancer Inst. 1994 86 1297 1302 10.1093/jnci/86.17.1297 1:STN:280:DyaK2czktlGltw%3D%3D 8064888
41. T. Köhler D. Lerche A. Meye C. Weisbrich O. Wagner Automated analysis of nucleic acids by quantitative PCR using DNA coated ready-to-use reaction tubes J. Lab. Med. 1999 23 408 414
42. H. Taubert P. Würl A. Meye et al. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma Cancer 1995 76 1187 1196 10.1002/1097-0142(19951001)76:7<1187::AID-CNCR2820760714>3.0.CO;2-4 1:CAS:528:DyaK2MXptFOgurw%3D 8630896
43. T. Köhler A.-K. Rost H. Remke Calibration and storage of DNA competitors used for contamination-protected competitive PCR Biotechniques 1997 23 722 726 10.2144/97234st07 9343699
44. K. Dukas P. Sarfati N. Vaysse L. Pradayrol Quantitation of changes in the expression of multiple genes by simultaneous polymerase chain reaction Anal. Biochem. 1993 215 66 72 10.1006/abio.1993.1555 1:CAS:528:DyaK2cXhs1Ck 7507650
45. M.C.M. Finnegan J.R. Goepel B.W. Hancock M.H. Goyns Investigation of the expression of housekeeping genes in Non-Hodgekin’s Lymphoma Leuk. Lymphoma 1993 10 387 393 10.3109/10428199309148565 1:STN:280:DyaK2c%2FjsVOrtg%3D%3D 8220138
46. E. Spanakis Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls Nucleic Acids Res. 1993 21 3809 3819 10.1093/nar/21.16.3809 1:CAS:528:DyaK3sXmsVaktb8%3D 8367299 309896
47. H. Wong W.D. Anderson T. Cheng K.T. Riabowol Monitoring mRNA expression by polymerase chain reaction: the “primer-dropping” method Anal. Biochem. 1994 223 251 258 10.1006/abio.1994.1581 1:CAS:528:DyaK2MXitleqt7Y%3D 7887471
48. H. Taubert A. Meye P. Würl p53 mutation type is associated with prognosis in soft tissue sarcoma patients Cancer Res. 1996 56 4134 4136 8797580 1:CAS:528:DyaK28XlslGgsbY%3D
49. B. Tanner J.G. Hengstler S. Laubscher et al. mdm2 mRNA expression is associated with survival in ovarian cancer Int. J. Cancer 1997 74 438 442 10.1002/(SICI)1097-0215(19970822)74:4<438::AID-IJC13>3.0.CO;2-5 1:CAS:528:DyaK2sXlslKjurg%3D 9291435
50. F. Courjal M. Cuny C. Rodriguez et al. DNA amplifications at 20q13 and mdm2 define distinct subsets of evolved breast and ovarian tumours Br. J. Cancer 1996 74 1984 1989 10.1038/bjc.1996.664 1:CAS:528:DyaK2sXotFKhsA%3D%3D 8980401 2074828
51. S.J. Qiu S.L. Ye Z.Q. Wu Z.Y. Tang Y.K. Liu The expression of the mdm2 gene may be related to the aberration of the p53 gene in human hepatocellular carcinoma J. Cancer Res. Clin. Oncol. 1998 124 253 258 10.1007/s004320050162 1:CAS:528:DyaK1cXlslOisLo%3D 9645455
52. P. Würl A. Meye Berger et al. Prognostic relevance of C-terminal mdm2 detection is enhanced by positivity in soft tissue sarcomas Diagn. Mol. Pathol. 1997 6 249 254 10.1097/00019606-199710000-00001 9458382
53. M. Gorospe X.T. Wang N.J. Holbrook p53-dependent elevation of p21 (Waf1) expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system Mol. Cell. Biol. 1998 18 1400 1407 10.1128/MCB.18.3.1400 1:CAS:528:DyaK1cXhtleiu78%3D 9488455 108853
54. K. Kaarniranta M. Elo R. Sironen et al. Hsp70 accumulation in chondrocytic cells exposed to high continous hydrostatic pressure co-incide with mRNA stabilization rather than transcriptional activation Proc. Natl. Acad. Sci. U.S.A. 1998 95 2319 24 10.1073/pnas.95.5.2319 1:CAS:528:DyaK1cXhsleit7g%3D 9482883 19331
55. N.E. Erondu J. Nwanko Y. Zhong M. Boes R.S. Bar Transcriptional and posttranscriptional regulation of insulin-like growth factor binding proteins by cyclic adenosinse 3′,5′ -monophosphate: messenger RNA stabilization is accompanied by decreased binding of a 42-kDa protein to a uridine-rich domain in the 3′-untranslated region Mol. Endocrinol. 1999 13 495 504 10077006 1:CAS:528:DyaK1MXhslWgtr4%3D
56. M.E. Perry J. Piette J.A. Zawadzki D. Harvey A.J. Levine The mdm2 gene is induced in response to UV-light in a p53 dependent manner Proc. Natl. Acad. Sci. U.S.A. 1993 90 11623 11627 10.1073/pnas.90.24.11623 1:CAS:528:DyaK2cXnt1Cqsw%3D%3D 8265599 48036
57. S. Ungar A. Vande-Meeren L. Tammilehto K. Linnainmaa K. Mattson B.I. Gerwin High levels of mdm2 are not correlated with the presence of wild-type p53 in human malignant mesothelioma cell lines Br. J. Cancer 1996 74 1534 1540 10.1038/bjc.1996.585 1:STN:280:DyaK2s%2Fos1KnsA%3D%3D 8932331 2074839
58. H. Taubert A. Meye P. Würl Soft tissue sarcomas and p53 mutations Mol. Med. 1998 4 365 372 10.1007/BF03401743 1:CAS:528:DyaK1cXksFKktbY%3D 10780879 2230279
59. L. Wu A.J. Levine Differential regulation of the p21/WAF-1 and mdm2 gene after highdose UV irradiation: p53-dependent p53-independent regulation of the mdm2 gene Mol. Med. 1997 3 441 451 10.1007/BF03401691 1:CAS:528:DyaK2sXlsVOksbk%3D 9260156 2230214
60. C.A. Midgley D.P. Lane p53 protein stability in tumour cells is not determined by mutation but is dependent on mdm2 binding Oncogene 1997 15 1179 1189 10.1038/sj.onc.1201459 1:CAS:528:DyaK2sXmt1Gju7g%3D 9294611
61. A. Kraus F. Neff M. Behn M. Schuermann K. Muenkel J. Schlegel Expression of alternatively spliced mdm2 transcripts correlates with stabilized wild-type p53 protein Int. J. Canc. 1999 80 930 934 10.1002/(SICI)1097-0215(19990315)80:6<930::AID-IJC20>3.0.CO;2-M 1:CAS:528:DyaK1MXhvVGgtbg%3D
62. S.N. Jones A.E. Roe L.A. Donehower A. Bradley Rescue of embryonic lethality in mdm2-deficient mice by absence of p53 Nature 1995 378 206 208 10.1038/378206a0 1:CAS:528:DyaK2MXptlSmtb0%3D 7477327
63. R. Montes de Oca Luna R.S. Wanger G. Lozano Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53 Nature 1995 378 203 206 10.1038/378203a0 1:STN:280:DyaK28%2FmvFOnsw%3D%3D 7477326